TrialX
Image

Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19)

Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19)

Recruiting
18 years and older
All
Phase N/A

Overview

One of the main challenges of the health crisis caused by the COVID-19 epidemic is the availability of beds in intensive care units (ICUs) and, more importantly, the need for invasive mechanical ventilation (IVM) because the ICUs are currently reserved for intubated patients.

The experiences of both China and Italy indicate that a certain number of COVID-19 patients will require mechanical ventilation. However, the limited number of resuscitation beds and ventilators requires strict use of these scarce resources. As a significant proportion about 5% to 10%, of patients initially admitted to hospital with COVID-19 will require ventilation, it is essential to anticipate their need for resuscitation to improve the rare resource of beds and ventilator shortages in intensive care units.

The hypothesis of the study is that, in proven or suspected hospitalised and oxygen-requiring COVID-19 patients, an early predictive clinical score, calculated over the three first days of admission may allow for an earlier identification of patients who will require intubation and transfer to an intensive care unit for orotracheal intubation

Eligibility

Inclusion Criteria:

  • Proven or expected COVID-19 patients hospitalised in a non-intensive care unit for less than 12 hours,
  • Patients requiring oxygen therapy,
  • Age 18 years old.

Exclusion Criteria:

  • Patients who are opposed to taking part in the study and who are opposed to the collection and use of the data that the study aims to collect.,
  • Patients who can not be intubated for medical reasons,
  • Pregnant women, parturient women or nursing mothers ,
  • Adult person subject to a legal protection measure (guardianship, curatorship, judicial safeguard),
  • Adults person who is unable to give consent and who is not subject to a legal protection measure,
  • Persons deprived of their liberty by a judicial or administrative decision,
  • Persons subject to psychiatric care under duress.

Study details
    Covid 19

NCT04376879

Central Hospital, Nancy, France

16 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.